Trial Profile
A compassionate use program of SM-88
Status:
Recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 19 Jun 2018
Price :
$35
*
At a glance
- Drugs Racemetyrosine (Primary)
- Indications Breast cancer; Colon cancer; Glioma; Lymphoma; Ovarian cancer; Pancreatic cancer; Prostate cancer; Sarcoma
- Focus Expanded access; Therapeutic Use
- 12 Jun 2018 Details data and results of analyses from first-in-human phase I study (CT profiles 700255130) and this compassionate use study (n=83) presented in a Tyme Technologies media release.
- 22 Jan 2018 New trial record
- 20 Jan 2018 Results of a retrospective analysis of 12 patients with advanced or metastatic pancreatic cancer from this and the phase 1 study, presented at the 2018 Gastrointestinal Cancers Symposium